| Application no. and date | 17715692.4 (espacenet) (Federated) (European Patent Register), 20170404 | | Patent/reg. no. and date | DK/EP 3439672, 20201125 | | Publication date | 20190213 | | Priority no. and date | EP 16163810, 20160405 | | EP pub. no. and date |
EP 3439672 20190213 | | Effective date | | | Applicant/owner | Janssen Vaccines & Prevention B.V., Archimedesweg 4
2333 CN Leiden, NL | | Applicant ref. no. | 1577998 | | Inventor | KRARUP, Anders, Archimedesweg 4-6
2333 CN Leiden, NL,
LANGEDIJK, Johannes, Petrus, Maria, Archimedesweg 4-6
2333 CN Leiden, NL | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 35/12 (2015.01) , A61K 39/12 (2006.01) , C07K 14/005 (2006.01) | | Title | STABILISEREDE OPLØSELIGE PRÆFUSIONS-RSV-F-PROTEINER | | Int. application no. | EP2017057962 | | Int. publication no. | WO2017174568 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
